Category: Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights

Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights

  1. Eli Lilly Pays Nektar $150M Up Front For Autoimmune Drug Rights  Xconomy
  2. Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune …  PR Newswire (press release)
  3. Nektar Therapeutics surges 10% on $150 mln Eli Lilly deal  MarketWatch
  4. Full coverage

from Business – Google News http://www.xconomy.com/indiana/2017/07/24/eli-lilly-pays-nektar-150m-up-front-for-autoimmune-drug-rights/

Advertisements